Barclays lowered the firm’s price target on RXO Inc. (RXO) to $22 from $24 and keeps an Overweight rating on the shares as part of a Q1 ...
In a report released today, Brandon Oglenski from Barclays maintained a Buy rating on RXO, Inc. (RXO – Research Report), with a price target of ...